You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

R-ISS III

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Newly Diagnosed Multiple Myeloma Trial in Germany (Isatuximab, Lenalidomide, Bortezomib)

Not yet recruiting
  • Newly Diagnosed Multiple Myeloma
  • Hamburg, Germany
  • +3 more
Dec 16, 2022

ISS Stage III Plasma Cell Myeloma, Plasma Cell Myeloma Trial in Rochester (procedure, drug, biological)

Not yet recruiting
  • ISS Stage III Plasma Cell Myeloma
  • Plasma Cell Myeloma
  • Bone Marrow Aspiration and Biopsy
  • +7 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Aug 9, 2022

Follicular Lymphoma (FL) Trial (biological, drug, other)

Not yet recruiting
  • Follicular Lymphoma (FL)
  • Tisagenlecleucel
  • +4 more
  • (no location specified)
May 24, 2023

ISS Stage I Plasma Cell Myeloma, ISS Stage II Plasma Cell Myeloma, ISS Stage III Plasma Cell Myeloma Trial in Atlanta

Active, not recruiting
  • ISS Stage I Plasma Cell Myeloma
  • +4 more
  • Pembrolizumab
  • Radiation Therapy
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Mar 2, 2022

Large B-Cell Lymphoma Trial in Xi'an (Glofitamab, Polatuzumab vedotin, Rituximab)

Not yet recruiting
  • Large B-Cell Lymphoma
  • Xi'an, China
    First Affiliated Hospital of Medical College of Xi'an Jiaotong U
Sep 14, 2023

Diffuse Large B Cell Lymphoma (DLBCL) Trial in Shanghai (Orelabrutinib + R-CHOP, Placebo + R-CHOP)

Recruiting
  • Diffuse Large B Cell Lymphoma (DLBCL)
  • Orelabrutinib + R-CHOP
  • Placebo + R-CHOP
  • Shanghai, Shanghai, China
    Shanghai Ruijing Hospital
Nov 28, 2022

Multiple Myeloma Trial in United States (bb2121, Fludarabine, Cyclophosphamide)

Active, not recruiting
  • Multiple Myeloma
  • bb2121
  • +3 more
  • Scottsdale, Arizona
  • +19 more
Jul 7, 2022

Body Temperature Changes Trial in Winnipeg (Blanketrol cooling device and water-perfused blankets, Blanketrol and Kool Kit,

Completed
  • Body Temperature Changes
  • Blanketrol cooling device and water-perfused blankets
  • +2 more
  • Winnipeg, Manitoba, Canada
    211 Max Bell Centre, University of Manitoba
Jan 19, 2023

B-Cell Lymphoma, Non-Hodgkin Lymphoma Trial in Worldwide (Glofitamab, Obinutuzumab (G), Rituximab (R))

Active, not recruiting
  • B-Cell Lymphoma
  • Non-Hodgkin Lymphoma
  • Birmingham, Alabama
  • +23 more
Dec 2, 2022

Amyotrophic Lateral Sclerosis Trial in Yangsan, Seoul (Lenzumestrocel, Riluzole, Placebo Comparator)

Recruiting
  • Amyotrophic Lateral Sclerosis
  • Lenzumestrocel
  • +2 more
  • Yangsan, Kyungsangnam-do, Korea, Republic of
  • +4 more
Mar 8, 2022

Functional Dyspepsia Trial in Iksan (DA-5212, DA-5212-R)

Not yet recruiting
  • Functional Dyspepsia
  • Iksan, Muwangro 895, Korea, Republic of
    Wonkwang University Hospital
Apr 24, 2023

Recurrent Vulvovaginal Candidiasis Trial in Austria, Poland, Slovakia (Prof-001, Fluconazole 150 mg, Placebo cream)

Active, not recruiting
  • Recurrent Vulvovaginal Candidiasis
  • Innsbruck, Tirol, Austria
  • +28 more
Sep 21, 2022

Treatment-na?ve Mantle Cell Lymphoma Trial in China (Orelabrutinib and R-CHOP, R-CHOP)

Not yet recruiting
  • Treatment-naїve Mantle Cell Lymphoma
  • Hefei, Anhui, China
  • +21 more
Dec 8, 2021

Cutaneous Squamous Cell Carcinoma Trial in Italy (Cemiplimab)

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Bagno A Ripoli, Firenze, Italy
  • +6 more
Jul 27, 2022

Relapsed Diffuse Large B-cell Lymphoma, Refractory DLBCL Trial in Worldwide (Polatuzumab Vedotin, Mabthera, Ifosfamide)

Recruiting
  • Relapsed Diffuse Large B-cell Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma
  • Polatuzumab Vedotin
  • +4 more
  • Graz, Austria
  • +62 more
Aug 2, 2022

Diffuse Large B-cell Lymphoma Trial in Beijing, Shanghai (R-CHOP(Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and

Recruiting
  • Diffuse Large B-cell Lymphoma
  • R-CHOP(Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone)
  • +2 more
  • Beijing, Beijing, China
  • +1 more
Aug 8, 2021

Extranodal NK/T-cell Lymphoma Trial (Sugemalimab, Placebo, Pegaspargase)

Not yet recruiting
  • Extranodal NK/T-cell Lymphoma
  • Sugemalimab
  • +4 more
  • (no location specified)
Jan 17, 2023

Respiratory Infection Trial in Seoul (DWKH, DWKH-R, Placebo)

Completed
  • Respiratory Infection
  • Seoul, Korea, Republic of
    Korea University Guro Hospital
Jan 4, 2023

Anemia, MDS Trial in Germany (Canakinumab Injection)

Recruiting
  • Anemia
  • Myelodysplastic Syndromes
  • Canakinumab Injection
  • Berlin, Germany
  • +5 more
Nov 8, 2022

Hypertriglyceridemia Trial in Canada, United States (ISIS apoC-III Rx, Placebo)

Completed
  • Hypertriglyceridemia
  • ISIS apoC-III Rx
  • Placebo
  • Farmville, North Carolina
  • +6 more
Jan 25, 2022

COVID-19 Trial in Campos Dos Goytacazes (AZVUDINE, AZVUDINE )

Completed
  • COVID-19
  • Campos Dos Goytacazes, RJ, Brazil
    Santa Casa de Misericordia de Campos
Aug 10, 2022

Idiopathic Thrombocytopenic Purpura Trial in Multiple Locations (R788, Placebo)

Active, not recruiting
  • Idiopathic Thrombocytopenic Purpura
  • Multiple Locations, Japan
    Research Site
Mar 22, 2022

Diffuse, Large B-Cell, Lymphoma Trial in China (Polatuzumab Vedotin, Bendamustine, Rituximab)

Completed
Has Results
  • Diffuse, Large B-Cell, Lymphoma
  • Polatuzumab Vedotin
  • +3 more
  • Beijing, China
  • +9 more
Jul 7, 2022

Glucose, High Blood Trial in Palm Beach Gardens (Human Insulin, Finger-actuated, Metered Pump Sprayer)

Not yet recruiting
  • Glucose, High Blood
  • Human Insulin
  • Finger-actuated, Metered Pump Sprayer
  • Palm Beach Gardens, Florida
    Langford Research Institute
Aug 3, 2022

Malaria Trial in Oxford (R21/Matrix-M, Rabies vaccine)

Active, not recruiting
  • Malaria
  • R21/Matrix-M
  • Rabies vaccine
  • Oxford, United Kingdom
    CCVTM, University of Oxford, Churchill Hospital
Jan 26, 2022